A multidimensional approach to frailty in emergency surgery for perforated peptic ulcer Authors: Muhammed Salih Süer, Serkan Demir, Ender Ergüder, Kaan Işık, Şener Balas Published: 2026 ABSTRACT BACKGROUNDPerforated peptic ulcer (PPU) remains a high-risk surgical emergency. Although sarcopenia has been proposed as an objective surrogate of frailty, its independent prognostic value in emergency surgery is unclear. This study evaluated sarcopenia within a multidimensional frailty framework incorporating nutritional, inflammatory, and clinical parameters.METHODSThis retrospective cohort study included adult patients who underwent emergency surgery for PPU at a tertiary center. Sarcopenia was assessed using computed tomography-derived psoas muscle area and psoas muscle index with population-specific cut-off values. Immunonutritional and inflammatory indices (hemoglobin–albumin–lymphocyte–platelet [HALP], neutrophil-to-lymphocyte ratio [NLR], platelet-to-lymphocyte ratio [PLR], and systemic immune-inflammation index [SII]) were calculated from admission laboratory data. The primary outcome was in-hospital mortality. Multivariable logistic regression and receiver operating characteristic (ROC) curve analyses were performed to identify independent predictors and discriminatory performance.RESULTSNinety-seven patients were included; 30.9% were sarcopenic. Sarcopenic patients exhibited lower serum albumin, higher inflammatory markers, higher clinical severity scores, and longer intensive care unit and hospital stays (all p<0.05). However, sarcopenia was not independently associated with in-hospital mortality. In multivariable analysis, advanced age (odds ratio [OR] 1.07, p=0.010) and low serum albumin (OR 0.75, p<0.001) were the strongest independent predictors of mortality. Low HALP score and elevated NLR and PLR were significantly associated with sarcopenia. ROC analysis showed that age and albumin had superior discriminatory ability for mortality compared with morphometric muscle parameters.CONCLUSIONIn PPU surgery, frailty is better characterized as a multidimensional biological phenotype rather than isolated muscle loss. While sarcopenia reflects increased vulnerability, mortality risk is more strongly driven by age and nutritional–inflammatory reserve. Integrated frailty assessment may improve risk stratification in emergency surgical patients. INTRODUCTION Perforated peptic ulcer (PPU) remains a life-threatening surgical emergency with considerable morbidity and mortality despite advances in operative techniques, antimicrobial therapy, and perioperative care. Mortality rates of 10–30% are still reported, particularly in older patients and those with limited physiological reserve.[1,2] Widely used risk stratification tools, such as the Boey score and the American Society of Anesthesiologists (ASA) physical status classification, assist clinical decision-making but largely reflect acute disease severity and comorbidity burden.[3,4] They provide limited insight into a patient’s baseline ability to tolerate surgical stress. Frailty has been increasingly discussed as a contributor to adverse outcomes in surgical populations.[5] Broadly, it describes diminished physiological reserve and reduced capacity to recover from acute stressors.[6] While frailty has been associated with poor outcomes in elective and oncologic surgery, its assessment in emergency settings remains challenging due to time constraints, acute presentation, and lack of functional baseline data.[7] Sarcopenia, characterized by reduced skeletal muscle mass and function, has been proposed as an objective, imaging-based parameter related to frailty.[8] Computed tomography (CT)-derived measurements, including psoas muscle area and psoas muscle index (PMI), are readily available from routine pre-operative imaging.[9] Several studies have linked these measures to adverse outcomes in acute abdominal conditions.[10,11] However, evidence regarding their independent prognostic value in emergency surgery is inconsistent, suggesting that muscle morphometry alone may not fully capture surgical vulnerability. Nutritional reserve and systemic inflammation also influence physiological response to acute illness.[12] Hypoalbuminemia is a well-recognized marker associated with post-operative morbidity and mortality, reflecting both nutritional and inflammatory states.[13] Composite immunonutritional indices, such as the hemoglobin–albumin–lymphocyte–platelet (HALP) score, and inflammatory markers including the neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and systemic immune-inflammation index (SII), have demonstrated prognostic relevance in acute surgical and critical care settings.[14-18] These four indices were chosen for their complementary biological profiles: NLR and PLR capture different inflammatory cell ratios, SII integrates three different lineages, and HALP uniquely combines nutritional and inflammatory parameters. Taken together, vulnerability in emergency surgery may be better understood through a multidimensional biological perspective that incorporates muscle reserve, nutritional status, inflammatory burden, and clinical severity rather than any single parameter alone. The aim of this study was to evaluate whether combining CT-based sarcopenia measures with immunonutritional and inflammatory indices improves risk stratification in patients undergoing surgery for PPU, and to clarify the relative contribution of sarcopenia within this broader physiological context. MATERIALS AND METHODS Study Design and Setting This retrospective observational cohort study was conducted in accordance with the STROCSS 2024 guideline for reporting cohort studies in surgery.[19] The study was performed at a tertiary referral academic hospital with a dedicated emergency general surgery service. This study was approved by the Ankara Etlik City Hospital Scientific Research Evaluation and Ethics Committee (Date: 10/06/2025, Decision no: AEŞH-BADEK2-2025-252), and the requirement for informed consent was waived due to the retrospective nature of the study (AEŞH-BADEK2-2025-252 Date: June 10, 2025). This study was conducted in accordance with the principles of the Declaration of Helsinki. Patient Selection During the study period (October 2022–April 2025), a total of 111 consecutive adult patients with intraoperatively confirmed PPU were screened for eligibility. Of these, 14 patients were excluded for the following reasons: Malignant gastric or duodenal perforation (n=4), traumatic perforation (n=1), and incomplete clinical or radiological data (n=9). After applying these criteria, 97 patients remained eligible and constituted the final study cohort. Data Collection Demographic characteristics, comorbid conditions, clinical presentation, laboratory parameters, operative findings, and post-operative outcomes were retrieved from electronic medical records and institutional databases. Disease severity was assessed using the Boey score, and perioperative risk was classified according to the ASA physical status classification. Clinical outcomes included post-operative complications, need for reoperation, intensive care unit (ICU) length of stay, total length of hospital stay, and in-hospital mortality. The Boey score assigns one point for each of the following: Presence of major medical illness, pre-operative shock (systolic blood pressure <90 mmHg), and duration of perforation exceeding 24 h (range 0–3).[3] Assessment of Sarcopenia and Morphometric Parameters Pre-operative abdominal CT scans performed at admission were reviewed for morphometric analysis. Skeletal muscle assessment was performed at the level of the third lumbar vertebra (L3), where available, using standardized measurement techniques. Psoas muscle area was measured bilaterally, and the PMI was calculated by normalizing total psoas area to patient height squared (cm2/m2). Sarcopenia was defined using sex-specific psoas muscle area and PMI cut-off values derived by Bahat et al.[20] from a large Turkish adult population on standardized L3-level CT measurements. This reference framework was deliberately selected to align the diagnostic threshold with the demographic and anthropometric characteristics of the present cohort, thereby reducing the misclassification that can arise when cut-offs developed in ethnically or anthropometrically discordant populations are externally applied. CT imaging at L3 reliably reflects total body skeletal muscle mass and is widely accepted as a surrogate for generalized muscle quantity. All measurements were performed manually by a single trained investigator blinded to clinical outcomes. Laboratory and Immunonutritional Parameters Laboratory values obtained at admission were recorded, including hemoglobin, leukocyte count, lymphocyte count, platelet count, C-reactive protein (CRP), and serum albumin levels. Inflammatory and immunonutritional indices were calculated as follows: NLR=Neutrophil count/Lymphocyte countPLR=Platelet count/Lymphocyte countSII=Platelet count×Neutrophil count/Lymphocyte countHALP=Hemoglobin (g/dL)×Albumin (g/dL)×Lymphocyte count (/L)/Platelet count (/L). NLR=Neutrophil count/Lymphocyte count NLR=Neutrophil count/Lymphocyte count PLR=Platelet count/Lymphocyte count PLR=Platelet count/Lymphocyte count SII=Platelet count×Neutrophil count/Lymphocyte count SII=Platelet count×Neutrophil count/Lymphocyte count HALP=Hemoglobin (g/dL)×Albumin (g/dL)×Lymphocyte count (/L)/Platelet count (/L). HALP=Hemoglobin (g/dL)×Albumin (g/dL)×Lymphocyte count (/L)/Platelet count (/L). Cut-off values for these indices were determined using receiver operating characteristic (ROC) curve analysis based on optimal Youden index values. Definition of Frailty Phenotype Frailty was conceptualized as a multidimensional biological phenotype, integrating morphometric sarcopenia parameters, nutritional reserve, systemic inflammatory burden, and clinical severity indicators. Rather than applying a single frailty score, this phenotype-based approach was adopted to better reflect physiological vulnerability in the emergency surgical setting. Statistical Analysis Statistical analyses were performed using iamovi statistical analysis software (version 2.7.17), built on the R statistical computing environment, developed by the jamovi project (Sydney, Australia). Continuous variables were assessed for normality using the Shapiro–Wilk test and are presented as median with interquartile range. Categorical variables are expressed as frequencies and percentages. Comparisons between groups were performed using the Mann–Whitney U-test for continuous variables and the χ2 test or Fisher’s exact test for categorical variables, as appropriate. Factors associated with in-hospital mortality were evaluated using binomial logistic regression analysis. Variables with clinical relevance and/or statistical significance in univariate analyses were entered into the multivariable model. Discriminatory performance of selected variables was assessed using ROC curve analysis, and area under the curve (AUC) values with 95% confidence intervals were reported. A two-sided p<0.05 was considered statistically significant. RESULTS A total of 97 patients were included in the study. Most patients were male (n=76, 78.4%), while 21 patients (21.6%) were female. Regarding body mass index (BMI), the majority of patients were of normal weight (n=58, 59.8%), followed by overweight patients (n=26, 26.8%). Obesity class I and II were observed in a small proportion of patients, and the number of underweight patients was limited. Sarcopenia was identified in 30 patients (30.9%), whereas 67 patients (69.1%) were classified as non-sarcopenic. Nearly, all perforations were located in the prepyloric region (n=94, 96.9%). Open surgery was the predominant surgical approach (n=90, 92.8%). Baseline patient characteristics are summarized in Table 1. Table 1Patient characteristics and clinical variables (n=97)VariableCategoryTotal (n=97) (%)SexMale76 (78.4)Female21 (21.6)BMI categoryUnderweight6 (6.2)Normal weight58 (59.8)Overweight26 (26.8)Obesity class I4 (4.1)Obesity class II3 (3.1)SarcopeniaAbsent67 (69.1)Present30 (30.9)Perforation sitePrepyloric94 (96.9)Duodenal bulb3 (3.1)Surgical approachOpen90 (92.8)Laparoscopic7 (7.2)Boey score030 (30.9)136 (37.1)217 (17.5)314 (14.4)ASA physical statusII45 (46.4)III43 (44.3)IV9 (9.3)Complications9 (9.3)Reoperation6 (6.2)Table 1 presents the demographic characteristics, basic clinical variables, and surgical data of the 97 patients included in the study. The gender distribution, body mass index classes, sarcopenia status, perforation location, surgical approach, Boey score, and ASA physical status classification of the patient group are included in the table. Post-operative complication and reoperation rates are also summarized. BMI: Body mass index; ASA: American Society of Anesthesiologists. Patient characteristics and clinical variables (n=97) Table 1 presents the demographic characteristics, basic clinical variables, and surgical data of the 97 patients included in the study. The gender distribution, body mass index classes, sarcopenia status, perforation location, surgical approach, Boey score, and ASA physical status classification of the patient group are included in the table. Post-operative complication and reoperation rates are also summarized. BMI: Body mass index; ASA: American Society of Anesthesiologists. Mortality-Based Comparisons When patients were stratified according to in-hospital mortality, significant differences were observed between survivors (n=80) and non-survivors (n=17) for several variables (Table 2). Male sex was significantly more frequent among survivors, whereas the proportion of female patients was higher in the mortality group (p=0.005). BMI category distribution differed significantly between groups (p=0.002), with a higher proportion of obese patients in the mortality group. No deaths occurred among underweight patients. Table 2Categorical variables according to mortalityVariableCategorySurvived (n=80) (%)Died (n=17) (%)pSexMale67 (83.8)9 (52.9)0.005Female13 (16.3)8 (47.1)BMI classUnderweight6 (7.5)0 (0.0)0.002Normal50 (62.5)8 (47.1)Overweight20 (25.0)6 (35.3)Obese (I–II)4 (5.0)3 (17.6)SarcopeniaNo57 (71.3)10 (58.8)0.314Yes23 (28.7)7 (41.2)Boey score030 (37.5)0 (0.0)<0.001135 (43.8)1 (5.9)214 (17.5)3 (17.6)31 (1.3)13 (76.5)ASA classII45 (56.3)0 (0.0)<0.001III31 (38.8)12 (70.6)IV4 (5.0)5 (29.4)ComplicationsNo75 (93.8)13 (76.5)0.053Yes5 (6.2)4 (23.5)ReoperationNo78 (97.5)13 (76.5)0.011Yes2 (2.5)4 (23.5)Table 2 compares patients divided into two groups based on mortality status: Survivors and those who died. Gender, body mass index classes, presence of sarcopenia, Boey score, ASA physical status classification, post-operative complications, and reoperation requirement were analyzed as categorical variables. Where appropriate, the Chi-square or Fisher’s exact test was used for intergroup comparisons. ASA: American Society of Anesthesiologists. Categorical variables according to mortality Table 2 compares patients divided into two groups based on mortality status: Survivors and those who died. Gender, body mass index classes, presence of sarcopenia, Boey score, ASA physical status classification, post-operative complications, and reoperation requirement were analyzed as categorical variables. Where appropriate, the Chi-square or Fisher’s exact test was used for intergroup comparisons. ASA: American Society of Anesthesiologists. The prevalence of sarcopenia was numerically higher among non-survivors; however, this difference did not reach statistical significance (p=0.314). In contrast, mortality was strongly associated with disease severity scores. No mortality was observed among patients with a Boey score of 0, whereas the majority of patients with a Boey score of 3 were in the mortality group (p<0.001). Similarly, mortality rates increased significantly with higher ASA physical status. No deaths occurred in ASA II patients, while mortality was significantly higher in ASA III and IV patients (p<0.001). Neither symptom duration nor the interval between admission and surgery was significantly associated with in-hospital mortality. Symptom duration showed no significant group difference (Mann–Whitney U, p=0.163) and poor discriminatory performance (AUC=0.608, p=0.160). Although surgery interval reached borderline significance in parametric testing (p=0.045), this finding was not supported by non-parametric analysis (p=0.729) or ROC analysis (AUC=0.525, p=0.758). Post-operative complications were more frequent in the mortality group, although this difference was of borderline statistical significance (p=0.053). The need for reoperation was significantly higher among non-survivors (p=0.011). Multivariable Analysis of in-Hospital Mortality Binomial logistic regression analysis was performed to identify independent predictors of in-hospital mortality (Table 3). Age, BMI, psoas muscle area, PMI, serum albumin, leukocyte count, and hemoglobin level were included in the model. Table 3Independent predictors of in-hospital mortality (binomial logistic regression)(a). Demographic and body composition modelPredictorOdds ratio (OR)95% CIpAge (years)1.071.02–1.130.010BMI1.001.00–1.000.202PMI0.990.99–1.000.285(b). Biochemical and inflammatory modelPredictorOdds ratio (OR)95% CIpAlbumin0.750.64–0.87<0.001Leukocyte count1.001.00–1.000.020Hemoglobin0.990.98–1.010.514Table 3 presents the results of binomial logistic regression analyses performed to identify independent predictors of in-hospital mortality. Table 3a shows the demographic and body composition model, while Table 3b presents the biochemical and inflammatory model. Variables were selected based on clinical relevance, and collinearity was avoided by not including overlapping morphometric parameters in the same model. For each predictor, the odds ratio (OR) with 95% confidence interval and p-value are reported. Model fit was assessed using McFadden’s R2, and discriminatory performance was evaluated using the area under the receiver operating characteristic curve (area under the curve), where applicable. Independent predictors of in-hospital mortality (binomial logistic regression) Table 3 presents the results of binomial logistic regression analyses performed to identify independent predictors of in-hospital mortality. Table 3a shows the demographic and body composition model, while Table 3b presents the biochemical and inflammatory model. Variables were selected based on clinical relevance, and collinearity was avoided by not including overlapping morphometric parameters in the same model. For each predictor, the odds ratio (OR) with 95% confidence interval and p-value are reported. Model fit was assessed using McFadden’s R2, and discriminatory performance was evaluated using the area under the receiver operating characteristic curve (area under the curve), where applicable. Increasing age was independently associated with higher mortality risk (odds ratio [OR] 1.07, 95% confidence interval [CI] 1.02–1.13, p=0.010). Serum albumin level showed a strong inverse association with mortality (OR 0.75, 95% CI 0.64–0.87, p<0.001). Leukocyte count was also significantly associated with mortality (p=0.020), although the effect size was small. BMI, hemoglobin level, psoas muscle area, and PMI were not independently associated with mortality. The overall model fit was moderate (McFadden R2=0.296). The discriminatory performance of the model was high, with an area under the ROC curve of 0.886. Comparison According to Sarcopenia Status Clinical and laboratory characteristics were compared between sarcopenic and non-sarcopenic patients (Table 4). Sarcopenic patients were older and had lower BMI values; however, these differences were not statistically significant. As expected, both psoas muscle area and PMI were significantly lower in the sarcopenic group (p<0.001 for both). Table 4Clinical and laboratory characteristics according to sarcopenia statusVariableNon-sarcopenic (n=67)Sarcopenic (n=30)pAge (years)54 (IQR 26)61 (IQR 28)0.12BMI24.50 (IQR 4.70)23.50 (IQR 5.20)0.08PMI610 (IQR 240)420 (IQR 210)<0.001Psoas muscle area175 (IQR 80)118 (IQR 65)<0.001Albumin38 (IQR 4)32 (IQR 6)<0.001Hemoglobin130 (IQR 40)118 (IQR 45)0.06CRP72 (IQR 150)138 (IQR 190)0.01NLR890 (IQR 980)1540 (IQR 1400)0.02PLR24 000 (IQR 29 000)54 000 (IQR 61 000)0.01SII2500 (IQR 2800)6200 (IQR 5100)0.003HALP310 (IQR 260)145 (IQR 180)<0.001Boey score ≥28 (11.9)12 (40.0)0.002ASA III–IV18 (26.9)18 (60.0)0.001ICU stay (days)1 (IQR 2)4 (IQR 6)<0.001Length of hospital stay (days)6 (IQR 3)11 (IQR 6)<0.001Mortality10 (14.9)7 (23.3)0.31Table 4 compares clinical and laboratory characteristics between patients grouped into sarcopenic and non-sarcopenic categories based on the presence of sarcopenia. Demographic data, morphometric muscle measurements, nutritional and inflammation markers, and clinical outcomes were included in the table. The Mann–Whitney U-test was used for continuous variables, and the Chi-square or Fisher’s exact test was used for categorical variables. CRP: C-reactive protein; IQR: Interquartile range; ASA: American Society of Anesthesiologists. Clinical and laboratory characteristics according to sarcopenia status Table 4 compares clinical and laboratory characteristics between patients grouped into sarcopenic and non-sarcopenic categories based on the presence of sarcopenia. Demographic data, morphometric muscle measurements, nutritional and inflammation markers, and clinical outcomes were included in the table. The Mann–Whitney U-test was used for continuous variables, and the Chi-square or Fisher’s exact test was used for categorical variables. CRP: C-reactive protein; IQR: Interquartile range; ASA: American Society of Anesthesiologists. Sarcopenic patients had significantly lower serum albumin levels (p<0.001) and higher inflammatory markers, including CRP (p=0.01), NLR (p=0.02), PLR (p=0.01), and SII (p=0.003). HALP scores were significantly lower in sarcopenic patients (p<0.001). High-risk clinical features were more frequent in the sarcopenic group, including Boey score ≥2 (p=0.002) and ASA class III–IV (p=0.001). Postoperatively, sarcopenic patients had significantly longer ICU stays and longer overall hospital stays (both p<0.001). Although mortality was numerically higher among sarcopenic patients, this difference was not statistically significant. Perforation diameter (median 1.0 cm; range 0.5–3.0) was not associated with in-hospital mortality (p=0.999). Although sarcopenic patients tended to have larger perforations, this difference did not reach statistical significance (p=0.057). Immunonutritional and Inflammatory Signature of Sarcopenia Unadjusted categorical analysis demonstrated significant associations between sarcopenia and several inflammatory–immunonutritional indices (Table 5). Low HALP score was strongly associated with sarcopenia (OR 9.14, 95% CI 2.31–36.2, p<0.001). High NLR (OR 2.85, 95% CI 1.06–7.63, p=0.03) and high PLR (OR 5.71, 95% CI 1.98–16.4, p=0.002) were also significantly associated with sarcopenia. Although high SII values were more frequent among sarcopenic patients, this association did not reach statistical significance. Table 5Association between inflammatory–immunonutritional indices and sarcopeniaIndexRisk categoryNon-sarcopenic (n=67) (%)Sarcopenic (n=30) (%)OR (95% CI) (%)pSII<9057.562 (92.5)25 (83.3)Reference≥9057.55 (7.5)5 (16.7)2.47 (0.65–9.35)0.19HALP>53064 (95.5)21 (70.0)Reference≤5303 (4.5)9 (30.0)9.14 (2.31–36.2)<0.001NLR<198957 (85.1)20 (66.7)Reference≥198910 (14.9)10 (33.3)2.85 (1.06–7.63)0.03PLR<63916.560 (89.6)18 (60.0)Reference≥63916.57 (10.4)12 (40.0)5.71 (1.98–16.4)0.002Table 5 categorically evaluates the relationship between inflammatory and immunonutritional indices and the presence of sarcopenia. Threshold values determined by ROC analyses were used for the systemic immune-inflammation index (SII), HALP score, neutrophil-lymphocyte ratio (NLR), and platelet-lymphocyte ratio (PLR). The association with sarcopenia is presented with unadjusted odds ratios (OR) and 95% confidence intervals (CI). Association between inflammatory–immunonutritional indices and sarcopenia Table 5 categorically evaluates the relationship between inflammatory and immunonutritional indices and the presence of sarcopenia. Threshold values determined by ROC analyses were used for the systemic immune-inflammation index (SII), HALP score, neutrophil-lymphocyte ratio (NLR), and platelet-lymphocyte ratio (PLR). The association with sarcopenia is presented with unadjusted odds ratios (OR) and 95% confidence intervals (CI). ROC curve analysis demonstrated that age, serum albumin, HALP score, PMI, and psoas muscle area all exhibited discriminatory ability for in-hospital mortality (Fig. 1). Age and albumin showed the highest performance. HALP demonstrated balanced discriminatory capacity, whereas PMI and psoas muscle area showed more limited performance compared with age and albumin. Receiver operating characteristic (ROC) curve analysis of mortality predictors. Figure 1 shows ROC curves predicting in-hospital mortality for age, serum albumin level, hemoglobin–albumin–lymphocyte–platelet score, psoas muscle area, and psoas muscle index. The diagonal line represents random discrimination. Each curve reflects the performance of the respective variable in distinguishing mortality. DISCUSSION In this study, we evaluated sarcopenia within a broader biological framework of frailty in patients undergoing emergency surgery for PPU. The principal finding was that while sarcopenia was common and strongly associated with adverse nutritional, inflammatory, and clinical features, it did not independently predict in-hospital mortality. Instead, parameters reflecting physiological reserve and systemic response – particularly age and serum albumin – emerged as the strongest independent determinants of mortality. Although PPU is an acute surgical emergency, the patient’s capacity to withstand its physiological stress is largely determined by chronic baseline biological reserve. Sarcopenia, as a slowly evolving condition reflecting cumulative loss of muscle mass and reserve, therefore does not act as a competing illness but as a pre-existing substrate that conditions host response to acute insult. Sarcopenia has been increasingly proposed as a surrogate marker of frailty, especially in surgical populations where functional frailty scales are difficult to apply.[21] In our cohort, sarcopenic patients clearly represented a more vulnerable subgroup, characterized by lower albumin levels, higher inflammatory markers, higher disease severity scores, and prolonged ICU and hospital stays. These observations are consistent with prior work showing that sarcopenia is more closely linked to increased morbidity than to mortality in emergency surgical settings, and they suggest that morphometric muscle loss alone may be insufficient to capture the full extent of physiological vulnerability in acute abdominal conditions. Direct comparison with the existing literature provides important context for our findings. Brincat et al.,[22] in a systematic review of frailty in emergency surgery for older adults, reported that composite frailty assessment outperformed isolated morphometric markers in predicting adverse outcomes. Wang et al.,[23] in a cohort of older patients with PPU, demonstrated that sarcopenia added incremental prognostic value beyond the PULP score but did not replace conventional clinical predictors. Similarly, Yu et al.,[24] in patients with peptic ulcer bleeding, found that immunonutritional status was more closely associated with short-term outcomes than sarcopenia alone. Our results align with these reports: sarcopenia identified a vulnerable phenotype but lost its independent prognostic weight once age and albumin were accounted for, reinforcing the observation that in acute surgical stress, nutritional and inflammatory reserve may be more immediately relevant than muscle morphometry. The discrepancy between univariate and multivariable findings deserves specific interpretation. Sarcopenia coexisted with – rather than replaced – other determinants of outcome, particularly malnutrition and systemic inflammation. Serum albumin, which integrates both nutritional status and acute-phase response, likely served as a more proximal biological marker of the patient’s immediate capacity to tolerate surgical stress, thereby absorbing much of the prognostic signal initially attributable to sarcopenia. The relationship between sarcopenia and immunonutritional indices offers additional mechanistic insight. Sarcopenic patients demonstrated significantly lower HALP scores and higher NLR and PLR values at presentation, indicating that even under an identical acute inflammatory insult, the magnitude of the host response differed systematically according to baseline muscle reserve.[25] This suggests that sarcopenia reflects not merely a structural deficit but a state of reduced biological resilience that modulates the patient’s response to acute stress.[26] ROC analysis demonstrated that morphometric muscle parameters retained discriminatory ability for mortality; however, their performance was inferior to that of age and albumin. This discrepancy between univariate discrimination and multivariable independence highlights the complex and overlapping biological pathways underlying frailty in emergency surgery. Taken together, these findings suggest that in PPU surgery, frailty is better understood as a composite phenotype integrating muscle reserve, nutritional status, inflammatory response, and clinical severity. Sarcopenia remains a relevant component of this phenotype, but its prognostic value appears to be mediated through broader biological vulnerability rather than acting as an isolated determinant of mortality. Limitations This study has several limitations. Its retrospective and single-center design may limit generalizability and introduce selection bias. Post hoc power analysis indicated that the current sample (n=97; sarcopenic n=30 vs. non-sarcopenic n=67) provided relatively low statistical power (two-sided α=0.05) to detect the observed 8.4%-point difference in mortality between sarcopenic and non-sarcopenic groups (23.3% vs. 14.9%; odds ratio 1.73; Cohen’s h=0.22). Furthermore, with only 17 in-hospital deaths, the events-per-variable ratio limited the stability of multivariable modeling. The reported odds ratios require external validation in larger, multicenter cohorts. Finally, psoas-based morphometry is widely used in emergency surgical research and correlates with whole-body muscle mass, it remains a regional surrogate and may not fully capture global skeletal muscle quality. CONCLUSION In patients undergoing emergency surgery for PPU, frailty is best conceptualized as a multidimensional biological phenotype rather than a single morphometric condition. Although sarcopenia was frequent and closely associated with malnutrition, systemic inflammation, and greater clinical severity, it did not independently predict in-hospital mortality. Instead, age and serum albumin – reflecting physiological reserve and acute systemic response – emerged as the strongest determinants of outcome. These findings suggest that effective risk stratification in PPU surgery should move beyond isolated muscle measurements and incorporate integrated markers of nutritional status, inflammatory burden, and clinical severity to better identify high-risk patients.